Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Seikagaku Corp.
DescriptionAdenosine A3 receptor agonist
Molecular Target Adenosine A3 receptor (ADORA3)
Mechanism of ActionAdenosine A3 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat Rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today